The Latest in Gynecologic Cancers: The ABCs of ADCs (antibody-drug conjugates)

Antibody drug conjugates, or ADCs, are one of the newest innovations in cancer treatment. In this special webinar, learn from our Perlmutter Cancer Center gynecologic oncologist team on how ADCs are revolutionizing the treatment of various gynecologic malignancies. Timestamps: 00:01:43 What are antibody-drug conjugates? (Dr. Kari Hacker) 00: 07:31 How Tivdak Is Used in Gynecologic Cancers (Dr. Olivia Khouri) 00:19:20 How Elahere (Mirvetuximab Soravtansine) Is Used in Gynecologic Cancers (Dr. Whitfield Growdon) 00:33:57 How Enhertu (Trastuzuman Deruxtecan) is Used in in Gyencologic Cancers (Dr. Marina Stasenko) 00:41:42 Discover ADC Clinical Trials Open at NYULH (Dr. Michelle Lightfoot) 00:54:22 Questions & Answers For the upcoming free events and the latest news from Perlmutter Cancer Center, subscribe to our monthly email newsletter: https://connect.nyulangone.org/email-... Learn more about how we screen and treat gynecologic cancers, visit: https://nyulangone.org/care-services/... Learn more about Dr. Kari Hacker: https://nyulangone.org/doctors/164956... Learn more about Dr. Olivia Khouri: https://nyulangone.org/doctors/124561... Learn more about Dr. Whitfield Growdon: https://nyulangone.org/doctors/166953... Learn more about Dr. Marina Stasenko: https://nyulangone.org/doctors/133640... Learn more about Dr. Michelle Lightfoot: https://nyulangone.org/doctors/169918... Learn more about Dr. Deanna Gerber: https://nyulangone.org/doctors/118499...